StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$31.43−0.81 (-2.50%)

Close on Nov 17, 2026Market cap $1.05BP/E –Yield –

SpyGlass Pharma r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $29.18M, up 46.0% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$29.18M+46.0%
FY2024Dec 31, 2024$19.98M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$10.94M–
Q1 FY2026Mar 31, 2026$8.54M–
Q2 FY2025Jun 30, 2025$7.33M–
Q1 FY2025Mar 31, 2025$6.05M–

More SpyGlass Pharma figures

See a number that looks wrong?